US 8202891
Quaternary ammonium compounds useful as muscarinic receptor antagonists
granted A61PA61P11/00A61P11/06
Quick answer
US patent 8202891 (Quaternary ammonium compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P11/08, A61P43/00